<DOC>
	<DOC>NCT00650078</DOC>
	<brief_summary>The purpose of the study is to compare the safety and efficacy, with regards to the signs and symptoms, of MR prednisone (Lodotra®) versus placebo in combination with standard Disease Modifying Anti-Rheumatic Drug (DMARD) treatment in patients with active rheumatoid arthritis.</brief_summary>
	<brief_title>Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Documented history of RA in agreement with ACR criteria DMARD treatment for RA greater than or equal to 6 months, with a stable dose greater than or equal to 6 weeks prior to screening visit Duration of morning stiffness greater than or equal to 45 minutes greater than or equal to 4 swollen joints (out of 28) greater than or equal to 4 tender joints (out of 28) Suffering from another disease, which requires glucocorticoid treatment during the study period Synovectomy within 4 months prior to study start Use of glucocorticoids: Continued use of systemic glucocorticoids within 4 weeks prior to screening visit Intermittent use of glucocorticoids within 2 weeks prior to screening visit. Joint injections within 6 weeks prior to screening visit Topical glucocorticoids must be stopped at screening visit Use of biologicals such as: tumor necrosis factor α (TNFα) inhibitors and other compounds within 5 serum half lives prior to screening visit Pregnancy or nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Signs and Symptoms</keyword>
	<keyword>Autoimmune Diseases</keyword>
	<keyword>Joint Diseases</keyword>
	<keyword>Arthritis</keyword>
	<keyword>Connective Tissue Diseases</keyword>
	<keyword>Arthritis, Rheumatoid</keyword>
	<keyword>Rheumatic Diseases</keyword>
	<keyword>Predniso(lo)ne</keyword>
</DOC>